"Patients will be treated at City of Hope, where the therapy was developed and previously evaluated in a small, physician-run study. That study demonstrated early yet promising safety and efficacy with MB-101, with one leptomeningeal glioblastoma patient experiencing a complete response."
That's the patient you are referring to I believe.
CHM Price at posting:
32.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)